These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 26775397)
21. Recommendations for Pathologic Evaluation of Reduction Mammoplasty Specimens: A Prospective Study With Systematic Tissue Sampling. Ambaye AB; Goodwin AJ; MacLennan SE; Naud S; Weaver DL Arch Pathol Lab Med; 2017 Nov; 141(11):1523-1528. PubMed ID: 28795842 [TBL] [Abstract][Full Text] [Related]
22. Lobular carcinoma in situ at percutaneous breast biopsy: surgical biopsy findings. Liberman L; Sama M; Susnik B; Rosen PP; LaTrenta LR; Morris EA; Abramson AF; Dershaw DD AJR Am J Roentgenol; 1999 Aug; 173(2):291-9. PubMed ID: 10430122 [TBL] [Abstract][Full Text] [Related]
23. Management of atypical lobular hyperplasia, atypical ductal hyperplasia, and lobular carcinoma in situ. Clauser P; Marino MA; Baltzer PA; Bazzocchi M; Zuiani C Expert Rev Anticancer Ther; 2016; 16(3):335-46. PubMed ID: 26780850 [TBL] [Abstract][Full Text] [Related]
24. Follow-up surgical excision is indicated when breast core needle biopsies show atypical lobular hyperplasia or lobular carcinoma in situ: a correlative study of 33 patients with review of the literature. Elsheikh TM; Silverman JF Am J Surg Pathol; 2005 Apr; 29(4):534-43. PubMed ID: 15767810 [TBL] [Abstract][Full Text] [Related]
25. Breast Cancer Detection by Preoperative Imaging in Reduction Mammaplasty Patients: A Single Center Study of 918 Patients. Merkkola-von Schantz PA; Kauhanen SMC; Jahkola TA; Krogerus LA; Hukkinen KS World J Surg; 2017 Aug; 41(8):2013-2019. PubMed ID: 28255630 [TBL] [Abstract][Full Text] [Related]
26. Screening breast magnetic resonance imaging in women with atypia or lobular carcinoma in situ. Schwartz T; Cyr A; Margenthaler J J Surg Res; 2015 Feb; 193(2):519-22. PubMed ID: 25277350 [TBL] [Abstract][Full Text] [Related]
27. Invasive mammary carcinoma after immediate and short-term follow-up for lobular neoplasia on core biopsy. Crisi GM; Mandavilli S; Cronin E; Ricci A Am J Surg Pathol; 2003 Mar; 27(3):325-33. PubMed ID: 12604888 [TBL] [Abstract][Full Text] [Related]
28. Breast Cancer Risk and Follow-up Recommendations for Young Women Diagnosed with Atypical Hyperplasia and Lobular Carcinoma In Situ (LCIS). McEvoy MP; Coopey SB; Mazzola E; Buckley J; Belli A; Polubriaginof F; Merrill AL; Tang R; Garber JE; Smith BL; Gadd MA; Specht MC; Guidi AJ; Roche CA; Hughes KS Ann Surg Oncol; 2015 Oct; 22(10):3346-9. PubMed ID: 26242364 [TBL] [Abstract][Full Text] [Related]
29. [Classification of preinvasive breast and carcinoma in situ: doubts, controversies, and proposal for new categorizations]. Dauplat MM; Penault-Llorca F Bull Cancer; 2004 Dec; 91 Suppl 4():S205-10. PubMed ID: 15899609 [TBL] [Abstract][Full Text] [Related]
30. Surgical excision of pure flat epithelial atypia identified on core needle breast biopsy. Prowler VL; Joh JE; Acs G; Kiluk JV; Laronga C; Khakpour N; Lee MC Breast; 2014 Aug; 23(4):352-6. PubMed ID: 24518220 [TBL] [Abstract][Full Text] [Related]
31. Frequency of clinically occult intraepithelial and invasive neoplasia in reduction mammoplasty specimens: a study of 516 cases. Dotto J; Kluk M; Geramizadeh B; Tavassoli FA Int J Surg Pathol; 2008 Jan; 16(1):25-30. PubMed ID: 18203780 [TBL] [Abstract][Full Text] [Related]
32. Magnetic resonance imaging-guided core needle breast biopsies resulting in high-risk histopathologic findings: upstage frequency and lesion characteristics. Weinfurtner RJ; Patel B; Laronga C; Lee MC; Falcon SL; Mooney BP; Yue B; Drukteinis JS Clin Breast Cancer; 2015 Jun; 15(3):234-9. PubMed ID: 25579460 [TBL] [Abstract][Full Text] [Related]
33. Breast cancer risk associated with atypical hyperplasia and lobular carcinoma in situ initially diagnosed on core-needle biopsy. Donaldson AR; McCarthy C; Goraya S; Pederson HJ; Sturgis CD; Grobmyer SR; Calhoun BC Cancer; 2018 Feb; 124(3):459-465. PubMed ID: 29023647 [TBL] [Abstract][Full Text] [Related]
34. Lobular neoplasia diagnosed on breast Core biopsy: frequency of carcinoma on excision and implications for management. Calhoun BC; Collie AM; Lott-Limbach AA; Udoji EN; Sieck LR; Booth CN; Downs-Kelly E Ann Diagn Pathol; 2016 Dec; 25():20-25. PubMed ID: 27806840 [TBL] [Abstract][Full Text] [Related]
35. The significance of lobular carcinoma in situ and atypical lobular hyperplasia of the breast. Lewis JL; Lee DY; Tartter PI Ann Surg Oncol; 2012 Dec; 19(13):4124-8. PubMed ID: 22847126 [TBL] [Abstract][Full Text] [Related]
36. Site-specific pathology in breast reduction mammoplasty. Long X; Wang XJ; Wang Y; Bai M; Song KX; Zhao R Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Aug; 34(4):409-12. PubMed ID: 22954128 [TBL] [Abstract][Full Text] [Related]
37. Carcinoma and atypical hyperplasia in reduction mammaplasty: increased sampling leads to increased detection. A prospective study. Ambaye AB; MacLennan SE; Goodwin AJ; Suppan T; Naud S; Weaver DL Plast Reconstr Surg; 2009 Nov; 124(5):1386-1392. PubMed ID: 20009822 [TBL] [Abstract][Full Text] [Related]
38. Histopathological findings and follow-up after prophylactic mastectomy and immediate breast reconstruction in 100 women from families with hereditary breast cancer. Isern AE; Loman N; Malina J; Olsson H; Ringberg A Eur J Surg Oncol; 2008 Oct; 34(10):1148-54. PubMed ID: 18434071 [TBL] [Abstract][Full Text] [Related]
39. Classic lobular carcinoma in situ and atypical lobular hyperplasia at percutaneous breast core biopsy: outcomes of prospective excision. Murray MP; Luedtke C; Liberman L; Nehhozina T; Akram M; Brogi E Cancer; 2013 Mar; 119(5):1073-9. PubMed ID: 23132235 [TBL] [Abstract][Full Text] [Related]
40. The role of fine-needle aspiration cytology and core biopsy in the diagnosis of proliferative and atypical breast lesions. Maygarden SJ Anat Pathol; 1997; 2():165-96. PubMed ID: 9575375 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]